Home  >  Products  >  TRDMT1 (tRNA aspartic acid methyltransferase 1) Blocking Peptide (the N terminal of protein) (100ug)
TRDMT1 (tRNA aspartic acid methyltransferase 1) Blocking Peptide (the N terminal of protein) (100ug)

TRDMT1 (tRNA aspartic acid methyltransferase 1) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TRDMT1 antibody (Catalogue #: ARP48627_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP48627
Size: 100 ug
Weight: 44kDa
Gene: 1787
Format: Lyophilized powder
Target: CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. TRDMT1 is a protein with similarity to DNA methyltransferases, but this protein does not display methyltransferase activity. The protein strongly binds DNA, suggesting that it may mark specific sequences in the genome.CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a protein with similarity to DNA methyltransferases, but this protein does not display methyltransferase activity. The protein strongly binds DNA, suggesting that it may mark specific sequences in the genome. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative names: DNMT2; M.HsaIIP; PuMet; RNMT1
See Full Product Listings >